AlphaLISA versus ELISA-based detection of interleukin 18 in healthy subjects and patients with end-stage renal disease.
Interleukin 18 (IL-18) is an important pro-inflammatory cytokine investigated in end-stage renal disease (ESRD) and several autoimmune and inflammatory diseases. The quantitative colorimetric sandwich ELISA test kit from MBL is the most frequently used ELISA kit for IL-18 detection. Recently, a new bead-based proximity assay named AlphaLISA was developed. The aim of this study was to compare the performance of these two kits and to evaluate aspects of sample handling on IL-18 measurements. Measurements of IL-18 were performed on plasma samples from 11 ESRD-patients in regular haemodialysis treatment and 10 healthy volunteers. We found a significant difference between assays corresponding to a factor of 6.4 (6.0; 6.7), p < 0.0001. Agreement was excellent with intra-class correlation coefficient 0.95. MBL had lower inter-assay variation, batch-to-batch variation and day-to-day variation. Spiking with recombinant IL-18 resulted in a mean recovery of 91 ± 7 (MBL) vs. 135 ± 17% (AlphaLISA), p < 0.0001. Both kits performed equally well when linearity was investigated. IL-18 was stable over a period of 424 days when plasma samples were stored at - 80°C. When blood samples were stored at room temperature mean IL-18 concentration changed significantly between 0, 1, 6, and 24 hours after sampling (p = 0.0213). No significant change was found with storage at 5°C. Severe haemolysis affected IL-18 measurements, whereas repeated freezing and thawing showed no effect. Mean IL-18 concentration was significantly higher in ESRD-patients compared to healthy subjects regardless of assay. Assay performance was best with the MBL-kit, although AlphaLISA was less time consuming when measuring plasma IL-18.